Zobrazeno 1 - 10
of 181
pro vyhledávání: '"J P, Bergerat"'
Autor:
F. Golfier, Philippe Wolf, J.-P. Bergerat, Sophie Caillard, E. Charlin, H. Flicoteaux, B. Moulin, Didier Ducloux, Laura Braun-Parvez, F. Rolle
Publikováno v:
American Journal of Transplantation. 10:2541-2546
An accidental transmission of placental choriocarcinoma (CC) from a multiorgan donor to four recipients is reported. The donor was a 26-year-old pregnant woman, died from a cerebral hemorrhage. Histological examination demonstrated the presence of a
Autor:
A. Urlacher, J. P. Bergerat, M. M. Tongio, M. L. North, Y. Mitsuishi, A. Falkenrodt, S. Mayer
Publikováno v:
Tissue Antigens. 26:271-285
"Natural antibodies" directed against antigens of the Major Histocompatibility Complex have been observed in aged mice but very seldom in humans. It is likely that HLA natural antibodies are more common than previously supposed: our results suggest t
Autor:
Jean-Pierre Ghnassia, P. Simon, Jean-Emmanuel Kurtz, C. Borel, S. Heymann, P. Dufour, L. Marcellin, A. Di Marco, G.-M. Jung, Georges Noël, J.-P. Bergerat
Publikováno v:
Cancer/Radiothérapie. 11:443-451
Resume Objectif de l'etude Evaluer de maniere retrospective trois modalites d'irradiation postoperatoire de sarcomes des tissus mous. Patients et methodes Entre 1990 et 2003, 89 patients d'âge median 50,8 ans, atteints d'un sarcome des membres chez
Autor:
S. Struski, R. Herbrecht, C. Gervais, P. Moskovtchenko, J.-P. Bergerat, V. Leymarie, M. Lessard, Bruno Audhuy, Bruno Lioure, Catherine Helias, C. Fohrer, Laurent Mauvieux, I. Mazurier, Annie Falkenrodt, Anne-Cécile Galoisy
Publikováno v:
Pathologie Biologie. 55:59-72
Resume Une etude cytologique, immunophenotypique et cytogenetique a ete realisee sur une serie de 136 patients (93 LLC, 43 lymphomes B) atteints de proliferations chroniques a cellules B matures dans le but de preciser les diagnostics, caracteriser e
Publikováno v:
Current Pharmacogenomics. 3:1-7
Publikováno v:
Cellular and Molecular Life Sciences. 62:53-64
Despite the uncontested role of p53 in cycle arrest/cell death after cisplatin treatment, to date the question whether wild-type p53 confers a resistant or sensitive status on the cell is still a matter of debate. Isogenic and isophenotypic human thy
Autor:
J M Denis, V Ganansia-Leymarie, Pierre Bischoff, Barbara Fischer, J. P. Bergerat, John Gueulette, S Benzina, Philippe Dufour
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 82:140-145
L'utilisation de rayonnements a transfert lineique d'energie (TLE) eleve, tels que les neutrons rapides et les ions carbone (hadrontherapie) offre de prometteuses perspectives en radiotherapie. Bien qu'en combinant la radiotherapie et la chimiotherap
Autor:
Philippe Dufour, Pierre Bischoff, David Coelho, Holl, J M Denis, John Gueulette, J. P. Bergerat, Barbara Fischer
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 80:644-649
The involvement of the tumor suppressor p53 gene in the sensitivity of many cell types towards low linear energy transfer (LET) radiation is now well established. However, little information is available on the relationship between p53 status of tumo
Autor:
J. P. Bergerat, M C M Mah-Becherel, J P Cazenave, J. Ceraline, Marie-Pierre Chenard, G. Deplanque, C Klein-Soyer
Publikováno v:
British Journal of Cancer
Neovascularisation is a key step in tumour growth and establishment of distant metastases. We have recently demonstrated that the thienopyridine SR 25989 an enantiomer of the anti-aggregant clopidogrel (Plavix®) lacking anti-aggregant activity, inhi